Rockefeller Capital Management L.P. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$1
-100.0%
13
-96.6%
0.00%
Q2 2022$25,000
+733.3%
386
+628.3%
0.00%
Q1 2022$3,000
+50.0%
53
+6.0%
0.00%
Q4 2021$2,000
-33.3%
50
-5.7%
0.00%
Q3 2021$3,000
+200.0%
53
+130.4%
0.00%
Q2 2021$1,000
-66.7%
23
-23.3%
0.00%
Q1 2021$3,000
-25.0%
30
-28.6%
0.00%
Q4 2020$4,000
-55.6%
42
-40.0%
0.00%
Q3 2019$9,000
+12.5%
700.0%0.00%
Q2 2019$8,000
+300.0%
70
+250.0%
0.00%
Q1 2019$2,000200.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders